138 related articles for article (PubMed ID: 20510555)
1. Serum tumour markers in gynaecological cancers.
Aggarwal P; Kehoe S
Maturitas; 2010 Sep; 67(1):46-53. PubMed ID: 20510555
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
[TBL] [Abstract][Full Text] [Related]
3. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
[TBL] [Abstract][Full Text] [Related]
4. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
Zhang M; Jiang W; Li G; Xu C
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
[TBL] [Abstract][Full Text] [Related]
5. Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?
Martinez S; Khakoo Y; Gilheeney S; Kramer K; Wolden S; Souweidane M; Dunkel IJ
Pediatr Blood Cancer; 2014 May; 61(5):853-4. PubMed ID: 24375894
[TBL] [Abstract][Full Text] [Related]
6. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
[TBL] [Abstract][Full Text] [Related]
7. Could ovarian choriocarcinoma be detected by maternal serum screening for Down syndrome?
Gauchez AS; Dreux S; Stéfani L; Mousseau M; Jouk PS; Muller F
Prenat Diagn; 2007 Jul; 27(7):682-4. PubMed ID: 17533625
[TBL] [Abstract][Full Text] [Related]
8. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
9. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
Wegman SJ; Parwani AV; Zynger DL
Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of AFP, its molecular variants and HCG in hepatoblastoma and childhood germ cell tumors.
Malati T
Clin Biochem; 2014 Jun; 47(9):734. PubMed ID: 24854689
[No Abstract] [Full Text] [Related]
11. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
12. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading.
Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F
J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060
[TBL] [Abstract][Full Text] [Related]
13. Significance of tumour markers in ovarian cancer.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
[No Abstract] [Full Text] [Related]
14. A need for cautious interpretation of elevated serum germ cell tumor markers in children. Review and own experiences.
Drozynska E; Bien E; Polczynska K; Stefanowicz J; Zalewska-Szewczyk B; Izycka-Swieszewska E; Ploszynska A; Krawczyk M; Karpinsky G
Biomark Med; 2015; 9(9):923-32. PubMed ID: 26329804
[TBL] [Abstract][Full Text] [Related]
15. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age.
Kondalsamy-Chennakesavan S; Hackethal A; Bowtell D; ; Obermair A
Gynecol Oncol; 2013 Jun; 129(3):467-71. PubMed ID: 23500084
[TBL] [Abstract][Full Text] [Related]
16. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
Uysal Z; Bakkaloğlu M
Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
18. New tumor markers: CA125 and beyond.
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms.
Lawrence AE; Fallat ME; Hewitt G; Hertweck P; Onwuka A; Afrazi A; Bence C; Burns RC; Corkum KS; Dillon PA; Ehrlich PF; Fraser JD; Gonzalez DO; Grabowski JE; Kabre R; Lal DR; Landman MP; Leys CM; Mak GZ; Overman RE; Rademacher BL; Raiji MT; Sato TT; Scannell M; Sujka JA; Wright T; Minneci PC; Deans KJ; Aldrink JH;
J Pediatr Surg; 2020 Jan; 55(1):122-125. PubMed ID: 31677824
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
Fan HY; Duan DM; Liu YF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]